Imagine being forced to sell your family’s belongings just to afford life-saving medicine for your baby. This is the heartbreaking reality for one Guernsey family, whose story sheds light on a system that often leaves parents feeling abandoned and desperate. But here’s where it gets controversial: should families ever have to choose between financial ruin and their child’s health? This question is at the heart of Kiely Luscombe’s struggle, as she and her partner grapple with the staggering cost of their nine-month-old son Arnold’s medication—£312.70 per bottle, or £3,500 annually. That’s right—a price tag that has pushed them to sell personal items just to keep their son alive.
Arnold’s journey began with relentless vomiting and stomach issues from just three weeks old, culminating in a rushed trip to Southampton Hospital in October 2025. Diagnosed with dysmotility and hypermotility, a digestive disorder that makes it nearly impossible for him to keep food down or have regular bowel movements, Arnold’s pain was so severe that he had to be held constantly. ‘His tummy was so tight it was hurting,’ Luscombe recalls. ‘He was arching his back in agony.’ The prescribed medication, Mebeverine, initially helped, but its effectiveness waned over time, forcing the family to increase the dosage—and the cost.
And this is the part most people miss: While Teena Bhogal, Chief Pharmacist, assures families that support is available through the Prescribing Support Unit (PSU), Luscombe claims no one informed her about the medication’s exorbitant price or potential alternatives. ‘We feel let down,’ she says. ‘We’ve tried everything, but we’re at the end of the road.’ Bhogal counters that clinicians can seek advice from the PSU to explore alternatives or add medications to the prescribing list, but Luscombe’s experience suggests a glaring gap in communication—or worse, a system that fails its most vulnerable.
Arnold’s medication, an oral solution typically prescribed for older children, is not funded by the States of Guernsey, leaving the family to bear the burden. Despite Arnold’s father returning to work—while managing the same chronic illness himself—and Luscombe caring for their son full-time, the financial strain is unbearable. ‘We’ve got six children between us,’ Luscombe explains. ‘This isn’t sustainable.’ Reducing Arnold’s dosage to stretch the medication only worsened his condition, leaving him swollen, vomiting, and in constant pain. ‘He didn’t have a quality of life,’ she says. ‘Why should that cost so much?’
Here’s the controversial twist: Bhogal claims the PSU has never received a request for this medication, urging clinicians to reach out. But if the system is truly supportive, why are families like Luscombe’s falling through the cracks? And why should parents have to sell their belongings or reduce their child’s medication just to make ends meet? Luscombe’s plea is both personal and universal: ‘Nobody deserves to be refused medication because they can’t afford it.’
As Luscombe awaits a disability allowance that could take months to arrive, she’s left asking: ‘Who will actually listen?’ Her story isn’t just about one family’s struggle—it’s a call to reevaluate a system that forces parents into impossible choices. What do you think? Is it fair for families to bear such costs, or should healthcare systems step in to ensure no child suffers due to financial barriers? Share your thoughts in the comments—this conversation needs your voice.
